← USPTO Trademark Applications

CRYSVITA CONNECT

Cancelled TM79228250 Kind: cancelled Mar 19, 2026

Abstract

Pharmaceutical preparations for the treatment of X-linked hypophosphatemia; Pharmaceutical preparations for the treatment of tumor-induced osteomalacia; Pharmaceutical preparations for the treatment of pediatric rickets; Pharmaceutical preparations comprising an anti-FGF23 (fibroblast growth factor 23) monoclonal antibody; Providing medical information, physical examination services, dietary and nutritional guidance

Filing Date

2017-11-08